Market Closed -
Japan Exchange
11:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
3,230
JPY
|
+0.47%
|
|
+1.25%
|
-1.22%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,25,342
|
1,61,603
|
1,64,177
|
1,41,444
|
1,16,879
|
1,14,598
|
-
|
-
|
Enterprise Value (EV)
1 |
1,66,311
|
1,00,313
|
1,00,691
|
79,530
|
56,370
|
51,631
|
50,456
|
48,021
|
P/E ratio
|
26.7
x
|
35.5
x
|
19.3
x
|
13.5
x
|
18.7
x
|
26.1
x
|
19.4
x
|
17.3
x
|
Yield
|
1.5%
|
1.92%
|
2.1%
|
2.41%
|
2.4%
|
2.48%
|
2.48%
|
2.48%
|
Capitalization / Revenue
|
2.06
x
|
1.59
x
|
1.59
x
|
1.28
x
|
1.13
x
|
1.12
x
|
1.08
x
|
1.06
x
|
EV / Revenue
|
1.52
x
|
0.99
x
|
0.98
x
|
0.72
x
|
0.55
x
|
0.51
x
|
0.48
x
|
0.44
x
|
EV / EBITDA
|
12.3
x
|
8.69
x
|
6.83
x
|
4.66
x
|
5.04
x
|
6.22
x
|
5
x
|
4.37
x
|
EV / FCF
|
1,47,62,172
x
|
-
|
-
|
-
|
1,09,86,079
x
|
-
|
1,37,63,119
x
|
97,66,238
x
|
FCF Yield
|
0%
|
-
|
-
|
-
|
0%
|
-
|
0%
|
0%
|
Price to Book
|
1.78
x
|
1.34
x
|
1.29
x
|
1.09
x
|
0.96
x
|
0.89
x
|
0.87
x
|
0.85
x
|
Nbr of stocks (in thousands)
|
39,673
|
38,754
|
38,270
|
37,870
|
34,994
|
35,479
|
-
|
-
|
Reference price
2 |
5,680
|
4,170
|
4,290
|
3,735
|
3,340
|
3,230
|
3,230
|
3,230
|
Announcement Date
|
13/05/19
|
15/05/20
|
14/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,09,643
|
1,01,799
|
1,02,995
|
1,10,179
|
1,03,261
|
1,02,000
|
1,06,000
|
1,08,000
|
EBITDA
1 |
13,507
|
11,538
|
14,745
|
17,081
|
11,179
|
8,300
|
10,100
|
11,000
|
EBIT
1 |
10,590
|
8,807
|
12,003
|
14,392
|
8,507
|
5,500
|
7,500
|
8,500
|
Operating Margin
|
9.66%
|
8.65%
|
11.65%
|
13.06%
|
8.24%
|
5.39%
|
7.08%
|
7.87%
|
Earnings before Tax (EBT)
1 |
11,642
|
6,273
|
11,900
|
14,591
|
9,044
|
5,600
|
7,600
|
8,600
|
Net income
1 |
8,435
|
4,598
|
8,587
|
10,569
|
6,649
|
4,400
|
5,900
|
6,650
|
Net margin
|
7.69%
|
4.52%
|
8.34%
|
9.59%
|
6.44%
|
4.31%
|
5.57%
|
6.16%
|
EPS
2 |
212.9
|
117.6
|
222.3
|
277.4
|
178.9
|
123.9
|
166.1
|
187.2
|
Free Cash Flow
|
11,266
|
-
|
-
|
-
|
5,131
|
-
|
3,666
|
4,917
|
FCF margin
|
10.28%
|
-
|
-
|
-
|
4.97%
|
-
|
3.46%
|
4.55%
|
FCF Conversion (EBITDA)
|
83.41%
|
-
|
-
|
-
|
45.9%
|
-
|
36.3%
|
44.7%
|
FCF Conversion (Net income)
|
133.56%
|
-
|
-
|
-
|
77.17%
|
-
|
62.14%
|
73.94%
|
Dividend per Share
2 |
85.00
|
80.00
|
90.00
|
90.00
|
80.00
|
80.00
|
80.00
|
80.00
|
Announcement Date
|
13/05/19
|
15/05/20
|
14/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
51,512
|
51,623
|
26,647
|
54,009
|
30,805
|
25,365
|
27,692
|
25,508
|
53,200
|
28,194
|
21,867
|
24,747
|
24,729
|
49,476
|
28,742
|
23,782
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
6,200
|
7,229
|
2,948
|
6,131
|
6,914
|
1,347
|
4,265
|
1,014
|
5,279
|
5,077
|
-1,849
|
2,515
|
1,437
|
3,952
|
1,839
|
-291
|
Operating Margin
|
12.04%
|
14%
|
11.06%
|
11.35%
|
22.44%
|
5.31%
|
15.4%
|
3.98%
|
9.92%
|
18.01%
|
-8.46%
|
10.16%
|
5.81%
|
7.99%
|
6.4%
|
-1.22%
|
Earnings before Tax (EBT)
|
6,366
|
7,353
|
-
|
6,793
|
6,964
|
-
|
4,414
|
-
|
5,412
|
5,195
|
-
|
2,572
|
-
|
4,049
|
1,994
|
-
|
Net income
1 |
4,592
|
5,411
|
2,263
|
4,916
|
5,264
|
389
|
3,155
|
768
|
3,923
|
4,158
|
-1,432
|
1,688
|
1,150
|
2,838
|
1,606
|
-44
|
Net margin
|
8.91%
|
10.48%
|
8.49%
|
9.1%
|
17.09%
|
1.53%
|
11.39%
|
3.01%
|
7.37%
|
14.75%
|
-6.55%
|
6.82%
|
4.65%
|
5.74%
|
5.59%
|
-0.19%
|
EPS
|
117.1
|
139.6
|
-
|
128.5
|
137.8
|
-
|
83.98
|
-
|
104.6
|
111.8
|
-
|
46.24
|
-
|
78.39
|
45.09
|
-
|
Dividend per Share
|
40.00
|
40.00
|
-
|
40.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
-
|
-
|
40.00
|
-
|
-
|
Announcement Date
|
05/11/19
|
02/11/20
|
05/11/21
|
05/11/21
|
04/02/22
|
13/05/22
|
01/08/22
|
04/11/22
|
04/11/22
|
06/02/23
|
15/05/23
|
04/08/23
|
02/11/23
|
02/11/23
|
05/02/24
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
59,031
|
61,290
|
63,486
|
61,914
|
60,509
|
62,967
|
64,142
|
66,577
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
11,266
|
-
|
-
|
-
|
5,131
|
-
|
3,666
|
4,917
|
ROE (net income / shareholders' equity)
|
6.9%
|
3.7%
|
6.9%
|
8.3%
|
5.2%
|
3.4%
|
4.5%
|
5%
|
ROA (Net income/ Total Assets)
|
6.96%
|
5.78%
|
7.68%
|
9.11%
|
5.64%
|
3.6%
|
4.7%
|
5.2%
|
Assets
1 |
1,21,212
|
79,490
|
1,11,813
|
1,16,028
|
1,17,819
|
1,22,222
|
1,25,532
|
1,27,885
|
Book Value Per Share
2 |
3,189
|
3,114
|
3,318
|
3,424
|
3,470
|
3,612
|
3,698
|
3,806
|
Cash Flow per Share
|
286.0
|
187.0
|
293.0
|
348.0
|
251.0
|
-
|
-
|
-
|
Capex
1 |
1,368
|
1,958
|
1,935
|
2,988
|
2,166
|
1,600
|
2,000
|
2,500
|
Capex / Sales
|
1.25%
|
1.92%
|
1.88%
|
2.71%
|
2.1%
|
1.57%
|
1.89%
|
2.31%
|
Announcement Date
|
13/05/19
|
15/05/20
|
14/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Last Close Price
3,230
JPY Average target price
3,200
JPY Spread / Average Target -0.93% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.22% | 735M | | +30.38% | 684B | | +26.51% | 568B | | -4.36% | 361B | | +19.30% | 329B | | +3.73% | 284B | | +16.70% | 240B | | +8.78% | 208B | | -7.93% | 200B | | +7.68% | 166B |
Other Pharmaceuticals
|